| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $152K | -92.7% |
| Cost of Revenue | $2.2M | -61.3% |
| Gross Profit | -$2.1M | +43.1% |
| R&D Expense | $1.8M | -66.6% |
| SG&A Expense | $8.8M | -21.5% |
| Operating Income | -$13.2M | +39.8% |
| Interest Expense | $3.3M | +343.6% |
| Pre-tax Income | -$34.5M | -66.7% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $209K | -90.3% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $1.5M | +4.8% |
| Current Assets | $1.9M | -55.8% |
| Total Assets | $7.0M | -34.0% |
| Current Liabilities | $20.8M | +107.3% |
| Long-term Debt | $9.2M | +4.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | +62.3% |
| Capital Expenditures | $1.2M | +0.0% |
| Investing Cash Flow | -$1.2M | +0.0% |
| Financing Cash Flow | $4.7M | -74.0% |
| Free Cash Flow | -$7.8M | +58.4% |
| — |
| Net Income | -$34.5M | -66.7% |
| EPS (Basic) | -$5.91 | -838.1% |
| EPS (Diluted) | -$5.91 | -838.1% |
| Total Liabilities |
| $20.9M |
| +8.8% |
| Stockholders' Equity | -$37.8M | -337.3% |